The CD20+CXCR4hiCD10+CD27-CD24+IgM+HLA-DR+ B cells in MC36 of HIV+ cART-naïve samples expressed CXCR5 compared to HIV+ pre-NHL (cART-naïve) samples. This evidence concerns the gene CXCR5 and non-Hodgkin lymphoma.